Quinoline as a Privileged Scaffold in Cancer Drug Discovery

作者: V. R. Solomon , H. Lee

DOI: 10.2174/092986711795328382

关键词:

摘要: Quinoline (1-azanaphthalene) is a heterocyclic aromatic nitrogen compound characterized by double-ring structure that contains benzene ring fused to pyridine at two adjacent carbon atoms. compounds are widely used as "parental" synthesize molecules with medical benefits, especially anti-malarial and anti-microbial activities. Certain quinoline-based also show effective anticancer activity. This broad spectrum of biological biochemical activities has been further facilitated the synthetic versatility quinoline, which allows generation large number structurally diverse derivatives. includes numerous analogues derived from substitution quinoline system, derivatization structure. its analogs have recently examined for their modes function in inhibition tyrosine kinases, proteasome, tubulin polymerization DNA repair. In this review, we summarized our knowledge on respect activities, mechanisms action, structure-activity relationship (SAR), selective specific activity against various cancer drug targets. particular, focus review vitro vivo context development refinement.

参考文章(162)
Kenyon G Daniel, Di Chen, Shirley Orlu, Qiuzhi Cindy Cui, Fred R Miller, Q Ping Dou, Clioquinol and pyrrolidine dithiocarbamate complex with copper to form proteasome inhibitors and apoptosis inducers in human breast cancer cells Breast Cancer Research. ,vol. 7, pp. 1- 12 ,(2005) , 10.1186/BCR1322
Timothy S. Lewis, Paul S. Shapiro, Natalie G. Ahn, Signal Transduction through MAP Kinase Cascades Advances in Cancer Research. ,vol. 74, pp. 49- 139 ,(1998) , 10.1016/S0065-230X(08)60765-4
Junyong Zhang, Xiaokang Ke, Chao Tu, Jun Lin, Jian Ding, Liping Lin, Hoong-Kun Fun, Xiaozeng You, Zijian Guo, Novel Cu(II)-quinoline carboxamide complexes: structural characterization, cytotoxicity and reactivity towards 5'-GMP. Biometals. ,vol. 16, pp. 485- 496 ,(2003) , 10.1023/A:1022577420708
Vivien E. Prise, George R. Pettit, Graham G. Dark, Sally A. Hill, Dai J. Chaplin, Gillian M. Tozer, Combretastatin A-4, an agent that displays potent and selective toxicity toward tumor vasculature Cancer Research. ,vol. 57, pp. 1829- 1834 ,(1997)
KC Nicolaou, R Scarpelli, B Bollbuck, B Werschkun, MMA Pereira, M Wartmann, K-H Altmann, D Zaharevitz, R Gussio, P Giannakakou, Chemical synthesis and biological properties of pyridine epothilones Chemistry & Biology. ,vol. 7, pp. 593- 599 ,(2000) , 10.1016/S1074-5521(00)00006-5
Frank Boschelli, Carlo Etienne, Kim Arndt, Danielle Nardin, Fei Ye, Philip Frost, Jennifer M Golas, James Gibbons, Judy Lucas, Diane H Boschelli, SKI-606, a 4-Anilino-3-quinolinecarbonitrile Dual Inhibitor of Src and Abl Kinases, Is a Potent Antiproliferative Agent against Chronic Myelogenous Leukemia Cells in Culture and Causes Regression of K562 Xenografts in Nude Mice Cancer Research. ,vol. 63, pp. 375- 381 ,(2003)
J A Escobedo, P J Barr, L T Williams, Role of tyrosine kinase and membrane-spanning domains in signal transduction by the platelet-derived growth factor receptor. Molecular and Cellular Biology. ,vol. 8, pp. 5126- 5131 ,(1988) , 10.1128/MCB.8.12.5126
Yujun George Zheng, Jiang Wu, Ziyue Chen, Masha Goodman, Chemical regulation of epigenetic modifications: opportunities for new cancer therapy. Medicinal Research Reviews. ,vol. 28, pp. 645- 687 ,(2008) , 10.1002/MED.20120
Yosef Yarden, Mark X. Sliwkowski, Untangling the ErbB signalling network Nature Reviews Molecular Cell Biology. ,vol. 2, pp. 127- 137 ,(2001) , 10.1038/35052073